Lexology January 16, 2025
2024 brought new considerations for healthcare organizations that are poised to extend into the new year. Below, we outline key areas to watch in 2025.
Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. As a result, sellers may be incentivized to explore market opportunities without requiring investors to gross-up purchase multiple premiums. This will likely broaden the number of investment opportunities for investors and sellers alike.
Additionally, many of the regulatory and antitrust headwinds that have disincentivized dealmaking over the past few years are expected to dissipate at the federal level. For instance, the Trump Administration...
Today's Sponsors
Today's Sponsor